BLOOMSBURY GENETIC THERAPIES LIMITED

BLOOMSBURY GENETIC THERAPIES LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameBLOOMSBURY GENETIC THERAPIES LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 13593877
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of BLOOMSBURY GENETIC THERAPIES LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is BLOOMSBURY GENETIC THERAPIES LIMITED located?

    Registered Office Address
    Building 1000 Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Cambridgeshire
    England
    Undeliverable Registered Office AddressNo

    What were the previous names of BLOOMSBURY GENETIC THERAPIES LIMITED?

    Previous Company Names
    Company NameFromUntil
    BLOOMSBURY GENE THERAPIES LIMITEDAug 31, 2021Aug 31, 2021

    What are the latest accounts for BLOOMSBURY GENETIC THERAPIES LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2025
    Next Accounts Due OnSep 30, 2026
    Last Accounts
    Last Accounts Made Up ToDec 31, 2024

    What is the status of the latest confirmation statement for BLOOMSBURY GENETIC THERAPIES LIMITED?

    Last Confirmation Statement Made Up ToAug 30, 2026
    Next Confirmation Statement DueSep 13, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToAug 30, 2025
    OverdueNo

    What are the latest filings for BLOOMSBURY GENETIC THERAPIES LIMITED?

    Filings
    DateDescriptionDocumentType

    Total exemption full accounts made up to Dec 31, 2024

    10 pagesAA

    Confirmation statement made on Aug 30, 2025 with updates

    5 pagesCS01

    Termination of appointment of John Edward Ilett as a secretary on Mar 05, 2025

    1 pagesTM02

    Resolutions

    Resolutions
    8 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolutions

    Company business 16/06/2025
    RES13
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Memorandum and Articles of Association

    34 pagesMA

    Termination of appointment of Adrien Felix Lemoine as a director on Apr 30, 2025

    1 pagesTM01

    Termination of appointment of Frank Armstrong as a director on Apr 07, 2025

    1 pagesTM01

    Termination of appointment of Sara Inmaculada Garcia Gomez as a director on Mar 19, 2025

    1 pagesTM01

    Termination of appointment of Michael Craig Diem as a director on Mar 18, 2025

    1 pagesTM01

    Termination of appointment of Andrea Hebe Spezzi as a director on Mar 20, 2025

    1 pagesTM01

    Confirmation statement made on Aug 30, 2024 with updates

    7 pagesCS01

    Statement of capital following an allotment of shares on Jul 19, 2024

    • Capital: GBP 109.35739
    4 pagesSH01

    Total exemption full accounts made up to Dec 31, 2023

    7 pagesAA

    Statement of capital following an allotment of shares on Mar 08, 2024

    • Capital: GBP 109.1481
    4 pagesSH01

    Registered office address changed from 30 Broad Street Great Cambourne Cambridge CB23 6HJ England to Building 1000 Cambridge Research Park Beach Drive Waterbeach Cambridgeshire CB25 9PD on Jan 08, 2024

    1 pagesAD01

    Confirmation statement made on Aug 30, 2023 with updates

    4 pagesCS01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10

    Satisfaction of charge 135938770001 in full

    1 pagesMR04

    Registration of charge 135938770003, created on Aug 22, 2023

    6 pagesMR01

    Statement of capital following an allotment of shares on Aug 21, 2023

    • Capital: GBP 108.79863
    4 pagesSH01

    Statement of capital following an allotment of shares on Apr 30, 2023

    • Capital: GBP 101.37001
    4 pagesSH01

    Total exemption full accounts made up to Dec 31, 2022

    7 pagesAA

    Statement of capital following an allotment of shares on Dec 07, 2022

    • Capital: GBP 91.25001
    4 pagesSH01

    Appointment of Mr John Edward Ilett as a secretary on Oct 03, 2022

    2 pagesAP03

    Confirmation statement made on Aug 30, 2022 with updates

    4 pagesCS01

    Who are the officers of BLOOMSBURY GENETIC THERAPIES LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    BRODY, Leigh Pauline, Dr
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    EnglandAmerican294709090001
    ILETT, John Edward
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Secretary
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    300846110001
    ARMSTRONG, Frank, Dr
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    United KingdomBritish165701050002
    DIEM, Michael Craig, Dr.
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    United StatesAmerican299396130001
    GARCIA GOMEZ, Sara Inmaculada, Dr.
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    EnglandSpanish299192220001
    GOLDMAN, Simon Aron, Dr
    Broad Street
    Great Cambourne
    CB23 6HJ Cambridge
    30
    England
    Director
    Broad Street
    Great Cambourne
    CB23 6HJ Cambridge
    30
    England
    United KingdomPolish254988610001
    LEMOINE, Adrien Felix
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    EnglandBritish,French299192140001
    RAHIM, Ahad Abdul
    29-39 Brunswick Square
    WC1N 1AX London
    Ucl School Of Pharmacy
    Director
    29-39 Brunswick Square
    WC1N 1AX London
    Ucl School Of Pharmacy
    United KingdomBritish286761910001
    SPEZZI, Andrea Hebe, Dr.
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    Director
    Cambridge Research Park
    Beach Drive
    CB25 9PD Waterbeach
    Building 1000
    Cambridgeshire
    England
    EnglandBritish299343450001

    Who are the persons with significant control of BLOOMSBURY GENETIC THERAPIES LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Ucl Business Ltd
    Gower Street
    WC1E 6BT London
    University College London
    England
    Aug 09, 2022
    Gower Street
    WC1E 6BT London
    University College London
    England
    No
    Legal FormPrivate Company Limited By Shares
    Country RegisteredEngland
    Legal AuthorityCompanies Act 2006
    Place RegisteredThe Registrar Of Companies For England And Wales
    Registration Number02776963
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Utf General Partner 2 Llp
    Benjamin Street
    EC1M 5QL London
    1
    England
    Apr 06, 2022
    Benjamin Street
    EC1M 5QL London
    1
    England
    No
    Legal FormLimited Liability Partnership
    Country RegisteredUnited Kingdom
    Legal AuthorityLimited Liability Partnership Act 2000
    Place RegisteredThe Registrar Of Companies For England And Wales
    Registration NumberOc425247
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Ahad Abdul Rahim
    29-39 Brunswick Square
    WC1N 1AX London
    Ucl School Of Pharmacy
    Aug 31, 2021
    29-39 Brunswick Square
    WC1N 1AX London
    Ucl School Of Pharmacy
    Yes
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0